Mohamed Eddouks is Professor at Moulay Ismail University, Faculty of Sciences and Techniques Errachidia, Morocco. He is a researcher in Physiology and Pharmacology with a master degree in Metabolic and Molecular Endocrinology from University of Paris vi, a specialized certificate in Endocrine Pharmacology from University of Paris vii and PhD degrees in Physiology and Pharmacology from University of Liege, Belgium and Sidi Mohammed Ben Abdellah University, Fez, Morocco. After his post-doctoral fellowship at Department of Physiology, Faculty of Medicine of Montreal, Canada, he is working for the last 16 years on medicinal plants. His work on antidiabetic and antihypertensive plants is well recognized globally. His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity and hypertension. His contribution to this field includes four international books and more than 80 peer-reviewed articles and book chapters of international repute. He is guest editor of American Journal of Pharmacology and Toxicology, lead guest editor of an annual special issue published by Evidence-Based and Complementary Alternative Medicine, regional editor of the following journals: American Journal of Food Technology, Journal of Applied Sciences, Trends in Applied Sciences Research and Singapore Journal of Scientific research; member of Editorial Board of several international journals. He has been honored with the first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development and the first Prize of the Federation of Arab Scientific Councils in 2016. He has been the Dean of Polydisciplinary Faculty of Errachidia from 2008 to 2012.

Ethnopharmacology

BioPharma research, currently working in the United States for Bristol-Myers Squibb. Before this, she headed a technology laboratory at Merck, covering comprehensive instrumentation in high tech fields such as fluorescence, imaging, flow cytometry, electrophysiology and luminescence for the entire range from early discovery to late stage clinical trials across all disease areas. In her current position at BMS, Dr. Ehrhardt directs the Clinical Cytometry team, covering a large portfolio of immunology, immuno-oncology, and other disease area exploratory and clinical studies. Her work focuses on the strategy and practicalities of biomarkers as tools to drive the development of urgently needed new medicines. This reaches form securing that biomarker assays are optimized to gather clear data in support of fast well founded decision making to systematically maximizing the information gathered from clinical samples to support hypothesis generation. Dr. Ehrhardt is currently on the board of different industry organizations, fostering innovation and collaboration between industry, academia and government organizations.

Immunology and Immuno-oncology

Professor Raid Alany has over 25 years of international experience in pharmacy education, pharmaceutics and drug delivery research. His academic journey spans three continents, namely, Asia, Oceania and Europe. He received his PhD in drug delivery from the University of Otago, Dunedin New Zealand in 2001; was appointed as a Lecturer at the School of Pharmacy, The University of Auckland, Auckland, New Zealand, in 2001 where he was responsible for establishing the first pharmaceutics curriculum at The University of Auckland. He was promoted to a Senior Lecturer in 2004, appointed as Head of Pharmaceutics in 2007, promoted to Senior Lecturer above the bar in February 2009; appointed as Honorary Associate Professor in 2011. He joined Kingston University London as Professor (Chair) of Pharmaceutics in January 2011 and was appointed as Research Director for the School of Pharmacy and Chemistry in December 2013. He has been appointed as the Inaugural Head of School of Life Sciences, Pharmacy and Chemistry on 1st of June 2015. Raid won several awards such as Microscopy New Zealand Young Scientists Award in 1999 The University of Auckland's Vice Chancellor's Early Career Research Excellence Award in 2003, the Controlled Release Society Veterinary Programme co-chair/ chair Distinguished Service Awards in 2008/2009 and the Spark Ideas Challenge, Uniservices Prize and Chiasma Prize in 2011. He consults for human and veterinary pharmaceutical companies in New Zealand and Singapore and is an inventor on several international patents.

Ophthalmic Drug Delivery, Lipid and Surfactant Based Drug Delivery Systems, Delivery of Antisense, Oligonucleotides and siRNA, In Situ Gelling Systems, Veterinary Pharmaceuticals

•Professor of Microbiology, High Institute of Public Health Alexandria University •Current position: Head of Microbiology& Immunology Department, Faculty of Pharmacy & Drug Manufacturing, Pharos University in Alexandria (2010- up till now) • Head of Microbiology Department, High Institute of Public health, University of Alexandria(2005 –2008) •Reviewer of the Bulletin of High Institute of Public Health (Bull HIPH), the Journal of the Egyptian Public Health Association, and Journal of the Medical Research Institute. •Supervised a number of research projects, master and doctor theses in different fields of microbiology

Pharmaceutical Microbiology, Infectious diseases, Infection Control, and Sanitary Microbiology

Professor Suleiman Olimat received his B.S in Pharmacy in 1980 from Aristotelian University, Greece and his Ph.D. in Natural Products Chemistry in 1986 from The University of Pittsburgh, USA. Currently, he is a professor in the department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Jordan. He has published more than 75 scientific papers in highly respected peer-reviewed journals. Prof. Olimat wrote a book in Arabic named "Chemistry of Natural Products, ALKALOIDS".

Prof. Olimat is interested in isolation and identification of the active principles of medicinal plant with focus on alkaloids.

Prof. Heyam Saad Ali has completed her PhD from Bradford University, UK. She is Head of Pharmaceutics Department, Dubai Pharmacy College, UAE. She has teaching and research experience of about 25 years. She has published more than 44 papers in reputed journals and has been serving as an editorial board member of several pharmaceutical Journals. She is a member of various pharmaceutical associations. In addition to attending more than 40 training courses, conferences and seminars in Quality Assurance systems.

Preformulation, Product formulation, Product testing and Stability, Quality Control, Assurance and GMP processes, Validation in Pharmaceutical development of conventional dosage forms.

Dr. Nahla El-Sayed El-Ashmawy is a professor of Biochemistry and Molecular Biology and is currently the Dean of Faculty of Pharmacy, University of Tanta. She has published more than 64 research articles in reputed journals and is an editorial board member of repute. She is a member of the “Promotion Committee for Associates and Professors", Supreme Council of Egyptian Universities. She is an associate trainer certified by “National Centre of Faculty and Leadership Development; NCFLD”. She is a reviewer and consultant of Quality Assurance of Higher Education certified by “National Authority for Quality Assurance and Accreditation of Education; NAQAAE”.

She studied the pathophysiological pathways of diseases to address new targets for drug discovery and to identify new non-invasive biomarkers for diagnosis or prognosis. She investigated the molecular mechanisms of drugs and the use of adjuvant or complementary therapy to improve therapeutic outcome. In vitro studies included differentiation of mesenchymal stem cells into hepatocytes and preparation of cytokine-induced killer cells.

Dr. Fathia El Sharkawi has obtained her PhD in biochemistry and molecular biology from Faculty of Pharmacy, Cairo University in 2000. She has completed postdoctoral studies in Germany from Paul Ehrlich institute in 2006 and Institute of virology, Essen University in 2007. She has been working in Faculty of Pharmacy, Helwan University since 2002. She is a member of many scientific societies and a reviewer for some international scientific journals. She is a member of Tempus project (Advanced Training and Life Long Program in Applied Health Science) with Linnaeus University, Sweden. Also she is a member of the scientific board of the drug discovery center at Helwan University. She has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute. Dr. Fathia El Sharkawi had previously worked as manager of scientific development in Kahira Pharmaceutical Company and as scientific affairs and registration consultant, Sigma Pharmaceutical Company, Egypt.

Cancer biomarkers, cancer therapy, hepatocellular carcinoma, gene therapy and genetic variability of different diseases, nanomedicine and drug targeting.

Ladislav Novotny was born in Czechoslovakia. He had obtained his Doctor of Pharmacy degree from Charles University in Prague in 1981; Doctor of Philosophy degree from Czechoslovak Academy of Sciences in Prague in 1984; Doctor of Science degree from Slovak Academy of Sciences, Bratislava in 1997. He is working as a Professor of Pharmaceutical Chemistry in Kuwait University since 1998. He served as a Dean of the Faculty of Pharmacy from 2003 to 2014. He contributed more than 140 articles to reputed international scientific journals.

Chemotherapy, Anticancer Studies, Cancer Chemotherapy, Cytotoxicity, Apoptosis, Medicinal Chemistry, Medicinal and Pharmaceutical Chemistry, Antimetabolites, Flavonoids, Secondary Metabolites

Rula M. Darwish is a Professor of Pharmaceutical Microbiology in University of Jordan.

Pharmaceutical Microbiology

Dr. Juliana Roos has completed her PhD from the University of Queensland, Australia owing to an International Postgraduate Research Scholarship (IPRS). Dr. Juliana Roos was then Research Fellow at the Monash University, Australia, at the Department of Clinical Epidemiology and Preventive Medicine working in the fields of Rheumatology, Meta-analysis and Health literacy. She is an Associate Professor at the Dubai Pharmacy College for the last year and has taught undergraduate and postgraduate courses in the Department of Clinical Pharmacy and Pharmacy Practice. She has over 15 publications and presentations papers in reputed journals and has been cited over 700 times.

Dr. Juliana Roos research interests focus on Meta-analyses and Systematic Reviews for renal function and cancer prevention. Health-literacy is another field of interest, investigating the level of medical-related information perceived by a patient. Dr. Juliana Roos is also interested in Rheumatology, exploring the gap between implemented evidence and routine clinical practice; and antimicrobials utilization in ICU.

Dr. Sawsan Abuhamdah is a Jordanian registered Pharmacist, has completed her PhD at the age of 30 years from Durham University, UK and postdoctoral studies from Granada Medical School, Department of Pharmacology, Spain and has won postdoctoral Fulbright Research Award at the University of Toledo, Department of pharmacology and experimental therapeutics, Ohio, USA, 2014-2015.Promoted to associate professor in 2014 at the faculty of pharmacy, University of Jordan, and now acting as Deputy Dean, College of Pharmacy, Al Ain University of Science and technology, Abu Dhabi, UAE. Dr. Abuhamdah has published many original research articles in peer-reviewed journals and participated in the preparation of many symposium abstracts. Dr. Abuhamdah is a member of the British Pharmacological Society (BPS), British Neuroscience Association (BNA), Sigma Phi Sigma pharmaceutical Sciences Honor Society, University of Toledo, USA, Jordan Pharmaceutical Association and has been serving as an editorial board member for the following journals: Journal of Innovations in Applied pharmaceutical Science (JIAPS.), Journal of Innovations in Pharmaceutical and Biological Sciences (JIPBS) , Journal of Drug Abuse and The Journal of Pharmacology and Alternative Medicine Therapeutic.

Pharmacology & Therapeutics, pharmaceutical sciences, Neurosciences, Neuroprotective approaches for neurodegenerative diseases, drug abuse.Isolation, identification and biological evaluation of plants secondary metabolites for CNS.

Professor Aburjai has completed his PhD in natural product chemistry and analysis from Milan University and he received his post doctorate from University of Kentucky. He published more than 200 papers in reputed journals, symposium abstract and patent applications. He has been serving as an editorial board member of reputable pharmaceutical journals. Also he has ample experience in drug development, registration and GMP implementation. He is official consultant of many regional and international pharmaceutical industries. Moreover he was ex. Dean of different faculties of pharmacy and has excellent administrative experience.

His research focus on development of innovative formulation of drugs based on medicinal plants and evaluation of their activity in vivo and in vitro. His interests also include development of new dosage forms and analytical methods based on natural products.

Prof. Hadeel T. AL-Hadithi has completed her PhD at the age of 29 years in Microbiology and became a full professor in1997.I was assigned as a staff member in Biology department, College of Science / University of Basrah since March 1980, then in the Faculty of Pharmacy / University of Jordan and currently at Faculty of Pharmacy / Al-Isra University. Participation in Conferences: 57 Publications, 86 Scientific Papers and 5 Academic Books & Booklets. Dissertations supervised for the degree of MSC: 25 and Ph.D: 8. I have two patents and participated as a member in many scientific and conference committees.

Pharmaceutical Microbiology

Dr Yahaya Hassan is a Professor of Clinical Pharmacy, Pharmacy Practice Department at Faculty of Pharmacy,Universiti Teknologi MARA (UiTM), Malaysia. He also serve as a consultant for Malaysian Qualifying Agency (MQA), Ministry of Higher Education of Malaysia and MQA panel member for Board of Pharmacy of Malaysia. He also serve as a committee member of Clinical Pharmacy Specialist development program for Pharmacy Division, Ministry of Health of Malaysia. Prof Yahaya obtained his B.Pharm from Universiti Sains Malaysia and Pharm.D. from University of Minnesota, USA. He has been lecturing at the faculty of Pharmacy for 32 years covering courses in clinical pharmacy, pharmacokinetics, advanced pharmacotherapeutics and pharmacy practice. He has successfully supervised over 20 research postgraduate students at the master’s and Ph.D levels, more than 200 master’s by coursework and published over 110 research papers in international journals and another 40 in regional and local journals.

clinical pharmacy, pharmacoepidemiology and pharmaceutical outcome study

Dr. Jagdish N. Sharma is currently a Professor in the Department of Pharmacology and Therapeutics of which he is the Founding Chairman, Faculty of Pharmacy, Kuwait University, Safat, Kuwait. He has also served as a Professor of Pharmacology at the Universiti Sains Malaysia, Penang, Malaysia, prior to joining Kuwait University in 1999. Prof. Sharma is an author of a book entitled “Topics in Mediators Pharmacology”, which has been published by the Nova Science Publishers Inc., N.Y., USA. Prof. Sharma is the Editor of a book Progress in Drug Research” series entitled “Recent Developments in the Regulation of Kinins” 2014 which is published by Springer Basel AG, Switzerland. He has been to numerous International conferences as invited speaker. Prof. Sharma has been holding several research grants for the support of his clinical and basic research activities and supervised PhD and MSc theses. He has been PhD external examiner and evaluator for promotions to the ranks of Associate Professor and Professor externally. In Malaysia, his research investigations were funded by the Ministry of Science and Technology, Malaysia. Currently his clinical priority research grant is funded by the Kuwait University research sector. He is the editorial board member of Pharmacy Times (USA) of Middle East from 2007 to date, Inflammopharmacology (UK) from 1997 to date, International Journal of Immunopathology and Pharmacology (Italy) from 2006 to date, European Journal of Inflammation (Italy) from 2006 to date, Archives of Medical Research (Mexico City) from 2006 to date, Clinical Medicine: Endocrinology and Diabetes (New Zealand) from 2008 to date, Clinical Medicine: Therapeutics (New Zealand) from 2009 to date, American Journal of Biomedical Sciences (USA) from 2009 to date and Journal of Pharmaceutical Technology and Drug Research (UK) from 2011 to date. He has more than 109 publication in reputed international biomedical journals.

Pharmacology and Therapeutics

Dr. Jagdish N. Sharma is currently a Professor in the Department of Pharmacology and Therapeutics of which he is the Founding Chairman, Faculty of Pharmacy, Kuwait University, Safat, Kuwait. He has also served as a Professor of Pharmacology at the Universiti Sains Malaysia, Penang, Malaysia, prior to joining Kuwait University in 1999. Prof. Sharma is an author of a book entitled “Topics in Mediators Pharmacology”, which has been published by the Nova Science Publishers Inc., N.Y., USA. Prof. Sharma is the Editor of a book Progress in Drug Research” series entitled “Recent Developments in the Regulation of Kinins” 2014 which is published by Springer Basel AG, Switzerland. He has been to numerous International conferences as invited speaker. Prof. Sharma has been holding several research grants for the support of his clinical and basic research activities and supervised PhD and MSc theses. He has been PhD external examiner and evaluator for promotions to the ranks of Associate Professor and Professor externally. In Malaysia, his research investigations were funded by the Ministry of Science and Technology, Malaysia. Currently his clinical priority research grant is funded by the Kuwait University research sector. He is the editorial board member of Pharmacy Times (USA) of Middle East from 2007 to date, Inflammopharmacology (UK) from 1997 to date, International Journal of Immunopathology and Pharmacology (Italy) from 2006 to date, European Journal of Inflammation (Italy) from 2006 to date, Archives of Medical Research (Mexico City) from 2006 to date, Clinical Medicine: Endocrinology and Diabetes (New Zealand) from 2008 to date, Clinical Medicine: Therapeutics (New Zealand) from 2009 to date, American Journal of Biomedical Sciences (USA) from 2009 to date and Journal of Pharmaceutical Technology and Drug Research (UK) from 2011 to date. He has more than 109 publication in reputed international biomedical journals

Pharmacology and Therapeutics